Grow

Search This Blog

Heath Insurers Are Denying More Drug Claims, Data Shows

July 18, 2025

Get link
Facebook
X
Pinterest
Email
Other Apps

Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major private insurers.

By Sarah Kliff | NYTimes | NYT > Business | Disclosure

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

Why India's Farmers Are Protesting

By Mujib Mashal, Emily Schmall and Russell Goldman via NYTimes | NYT > Business | Disclosure

Melio Payments: The Unicorn Revolutionizing Small Business Payments in North America

Melio Payments: The Unicorn Revolutionizing Small Business Payments in North America In the complex landscape of B2B payments, where tradition often trumps innovation, one company has emerged as a game-changer for America's small business community. Melio Payments, the Israeli-founded fintech unicorn valued at over $1.3 billion, is transforming how small and medium-sized businesses (SMBs) manage their financial transactions, bringing them firmly into the digital age. From Startup to Unicorn: Melio's Meteoric Rise Melio's journey to unicorn status is a testament to the urgent need for modernized B2B payment solutions. The company achieved its $1.3 billion valuation in January 2021 after raising $110 million in funding, demonstrating remarkable growth during a period when digital transformation became critical for business survival. This growth was particularly pronounced during the COVID-...

The Republican Tax Bill Could Sharply Slow E.V. Sales

The measure, passed by the House, would roll back incentives for people to buy electric vehicles and for automakers to make them in the U.S. By Jack Ewing | NYTimes | NYT > Business | Disclosure

Peter Seidler, Big-Spending San Diego Padres Owner, Dies at 63

Under Seidler’s leadership, the team’s payroll grew to one of the largest in Major League Baseball. By Jesus Jiménez | NYTimes | NYT > Business | Disclosure

The Markets Cheer Trump’s Treasury Pick, Scott Bessent

Investors seemed to signal their approval for Scott Bessent as a safe choice to implement the president-elect’s economic agenda. By Andrew Ross Sorkin, Ravi Mattu, Bernhard Warner, Sarah Kessler, Michael J. de la Merced and Lauren Hirsch | NYTimes | NYT > Business | Disclosure

Heath Insurers Are Denying More Drug Claims, Data Shows

Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major private insurers.

Comments

Post a Comment